ADDEX INCREASES ISSUED SHARE CAPITAL TO CREATE TREASURY SHARES

Addex Therapeutics announced the issuance of 93 million new registered shares at CHF 0.01 nominal value, fully subscribed by its wholly-owned subsidiary Addex Pharma S.A. The move increases issued share capital to CHF 3,116,544.96 while maintaining unchanged outstanding shares, designed to provide additional future financing flexibility for the clinical-stage biopharmaceutical company.